{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:56:49Z","timestamp":1783382209517,"version":"3.54.6"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["CA230573"],"award-info":[{"award-number":["CA230573"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcyt.2026.102913","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:00:18Z","timestamp":1779433218000},"page":"102913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3702-7173","authenticated-orcid":false,"given":"Mostafa","family":"Seblani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4905-0619","authenticated-orcid":false,"given":"Serge","family":"Yaacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-7892","authenticated-orcid":false,"given":"Patrick J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-2699","authenticated-orcid":false,"given":"Dalia","family":"Haydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2026.102913_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.02.002","article-title":"Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs","volume":"5","author":"Darragh","year":"2024","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0002","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/s41467-021-26135-9","article-title":"The GPR171 pathway suppresses T cell activation and limits antitumor immunity","volume":"12","author":"Fujiwara","year":"2021","journal-title":"Nat Comms"},{"key":"10.1016\/j.jcyt.2026.102913_bib0003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-025-02009-9","article-title":"Neurotransmitter power plays: the synaptic communication nexus shaping brain cancer","volume":"13","author":"Mondal","year":"2025","journal-title":"Acta Neuropathologica Comms"},{"issue":"17","key":"10.1016\/j.jcyt.2026.102913_bib0004","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.neuron.2025.07.012","article-title":"The neuroscience of brain cancers","volume":"113","author":"Monje","year":"2025","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102913_bib0005","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"issue":"7961","key":"10.1016\/j.jcyt.2026.102913_bib0006","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna","year":"2023","journal-title":"Nature"},{"issue":"7986","key":"10.1016\/j.jcyt.2026.102913_bib0007","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","article-title":"Glioma synapses recruit mechanisms of adaptive plasticity","volume":"623","author":"Taylor","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102913_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70556","article-title":"Neurotransmitters and immunity: molecular mechanisms, biological functions, diseases, and potential therapeutic targets","volume":"6","author":"Li","year":"2025","journal-title":"MedComm"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102913_bib0009","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.it.2007.07.005","article-title":"The emergence of neurotransmitters as immune modulators","volume":"28","author":"Franco","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2026.102913_bib0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66706","article-title":"Sensing the world and its dangers: an evolutionary perspective in neuroimmunology","volume":"10","author":"Kraus","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s44466-026-00028-2","article-title":"Emerging roles of immune cell-derived neurotransmitters in immunity and disease","volume":"2","author":"Ng","year":"2026","journal-title":"Immun Inflammat"},{"key":"10.1016\/j.jcyt.2026.102913_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1118637","article-title":"Neurotransmitters: promising immune modulators in the tumor microenvironment","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"issue":"43","key":"10.1016\/j.jcyt.2026.102913_bib0013","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1038\/s41388-022-02479-4","article-title":"Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment","volume":"41","author":"Battaglin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jcyt.2026.102913_bib0014","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","article-title":"The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer","volume":"15","author":"Hou","year":"2024","journal-title":"Nat Comms"},{"issue":"14","key":"10.1016\/j.jcyt.2026.102913_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.04.032","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.jcyt.2026.102913_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.05.031","article-title":"Cholinergic neuronal activity promotes diffuse midline glioma growth through muscarinic signaling","volume":"188","author":"Drexler","year":"2025","journal-title":"Cell"},{"issue":"8061","key":"10.1016\/j.jcyt.2026.102913_bib0017","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-025-08634-7","article-title":"Brain-wide neuronal circuit connectome of human glioblastoma","volume":"641","author":"Sun","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2026.102913_bib0018","article-title":"Mechanisms and therapeutic implications of glioma-neuron interactions","volume":"629","author":"Wang","year":"2025","journal-title":"Ca Lett"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102913_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102544","article-title":"Prognostic neurotransmitter receptors genes are associated with immune response, inflammation and cancer hallmarks in brain tumors","volume":"14","author":"Belotti","year":"2022","journal-title":"Cancers"},{"issue":"7885","key":"10.1016\/j.jcyt.2026.102913_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","article-title":"B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0021","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltac010","article-title":"Adrenergic signaling regulation of macrophage function: do we understand it yet?","volume":"2","author":"Freire","year":"2022","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jcyt.2026.102913_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01869","article-title":"Critical neurotransmitters in the neuroimmune network","volume":"11","author":"Hodo","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102913_bib0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbi.2019.04.002","article-title":"Mouse T cells express a neurotransmitter-receptor signature that is quantitatively modulated in a subset and activation dependent manner","volume":"80","author":"Rosenberg","year":"2019","journal-title":"Brain, Behav, Immun"},{"issue":"1\u20132","key":"10.1016\/j.jcyt.2026.102913_bib0024","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","article-title":"GABA, a natural immunomodulator of T lymphocytes","volume":"205","author":"Bjurst\u00f6m","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"15","key":"10.1016\/j.jcyt.2026.102913_bib0025","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","article-title":"GABAergic signaling by cells of the immune system: more the rule than the exception","volume":"78","author":"Bhandage","year":"2021","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102913_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251632","article-title":"Activation of GABA(A) receptors inhibits T cell proliferation","volume":"16","author":"Sparrow","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(98)00264-1","article-title":"GABA(A) receptors mediate inhibition of T cell responses","volume":"96","author":"Tian","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/2326-6066.CIR-17-0401","article-title":"\u03b2-adrenergic signaling impairs antitumor CD8+ T-cell responses to B-cell lymphoma immunotherapy","volume":"6","author":"Nissen","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"7982","key":"10.1016\/j.jcyt.2026.102913_bib0029","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b21-adrenergic receptor links sympathetic nerves to T cell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","article-title":"\u03b2-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress","volume":"68","author":"Qiao","year":"2018","journal-title":"Ca Immunol, Immunother: CII"},{"issue":"7965","key":"10.1016\/j.jcyt.2026.102913_bib0031","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","article-title":"Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors","volume":"618","author":"Zhu","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102913_bib0032","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","article-title":"Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor","volume":"109","author":"Le\u00f3n-Ponte","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102913_bib0033","article-title":"Serotonin receptor 5-HT2A as a potential target for HCC immunotherapy","volume":"13","author":"Tay","year":"2025","journal-title":"J Immunother Can"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102913_bib0034","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.153.2.489","article-title":"Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo","volume":"153","author":"Aune","year":"1994","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102913_bib0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000079411","article-title":"5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes","volume":"11","author":"Sempere","year":"2004","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0036","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/apha.12476","article-title":"Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases","volume":"216","author":"Levite","year":"2016","journal-title":"Acta Physiologica"},{"key":"10.1016\/j.jcyt.2026.102913_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00192","article-title":"Dopamine receptor D5 signaling plays a dual role in experimental autoimmune encephalomyelitis potentiating Th17-mediated immunity and favoring suppressive activity of regulatory T-cells","volume":"12","author":"Osorio-Barrios","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13075-023-03071-1","article-title":"Dopamine D2 receptor on CD4+ T cells is protective against inflammatory responses and signs in a mouse model of rheumatoid arthritis","volume":"25","author":"Wang","year":"2023","journal-title":"Arthrit Res Ther"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102913_bib0039","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","article-title":"The neurotransmitter glutamate and human T cells: Glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells","volume":"121","author":"Ganor","year":"2014","journal-title":"J Neural Trans"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102913_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112772","article-title":"Glutamate receptor-T cell receptor signaling potentiates full CD8+ T cell activation and effector function in tumor immunity","volume":"28","author":"de Aquino","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3724\/abbs.2025216","article-title":"Role of the neurotransmitter-receptor pathway in T-cell tumor immunology and cancer immunotherapy","volume":"58","author":"Fan","year":"2025","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.jcyt.2026.102913_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2026.102015","article-title":"Neurotransmitters: key regulators of the tumor immune microenvironment","volume":"81","author":"Zhang","year":"2026","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jcyt.2026.102913_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1596499","article-title":"CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence","volume":"16","author":"Yaacoub","year":"2025","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.jcyt.2026.102913_bib0044","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/0008-5472.CAN-21-4084","article-title":"Dopamine signaling promotes tissue-resident memory differentiation of CD8+ T cells and antitumor immunity","volume":"82","author":"Chen","year":"2022","journal-title":"Ca Res"},{"issue":"7735","key":"10.1016\/j.jcyt.2026.102913_bib0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","article-title":"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome","volume":"564","author":"Staedtke","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102913_bib0046","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1016\/j.ymthe.2024.08.028","article-title":"Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer","volume":"32","author":"Ajmal","year":"2024","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0047","article-title":"Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures","volume":"7","author":"Pascuzzo","year":"2025","journal-title":"Neuro-Oncol Adv"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102913_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.12.015","article-title":"A GAPDH serotonylation system couples CD8+ T cell glycolytic metabolism to antitumor immunity","volume":"84","author":"Wang","year":"2024","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102913_bib0049","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/CM9.0000000000003046","article-title":"Targeting metabolism to improve CAR-T cells therapeutic efficacy","volume":"137","author":"Liu","year":"2024","journal-title":"Chin Med J"},{"key":"10.1016\/j.jcyt.2026.102913_bib0050","article-title":"Glutamine synthetase deficiency enhances CD8 T cell survival and stress resilience in the tumor microenvironment","author":"Fisher-Gupta","year":"2025","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102913_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102913_bib0052","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","article-title":"Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization","volume":"29","author":"Liu","year":"2021","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102913_bib0053","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s42255-022-00638-1","article-title":"GAB functions as a bioenergetic and signalling gatekeeper to control T cell inflammation","volume":"4","author":"Kang","year":"2022","journal-title":"Nat Metabol"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102913_bib0054","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1159\/000542404","article-title":"Overcoming GABA-induced treg suppression of immunity by ABAT to augment CD8+T cell antitumor immune response in liver cancer","volume":"186","author":"Han","year":"2024","journal-title":"Int Arch Allerg Immunol"},{"key":"10.1016\/j.jcyt.2026.102913_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105217","article-title":"GABA-mediated inhibition of human CD4+ T cell functions is enhanced by insulin but impaired by high glucose levels","volume":"105","author":"Jin","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jcyt.2026.102913_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.617658","article-title":"T cells plead for rejuvenation and amplification; with the brain\u2019s neurotransmitters and neuropeptides we can make it happen","volume":"12","author":"Levite","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102913_bib0057","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00540-025-03533-7","article-title":"Intravenous anesthetic propofol suppresses T cell\u2013dependent antibody production in mice","volume":"39","author":"Hiraoka","year":"2025","journal-title":"J Anesthes"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0058","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69987-z","article-title":"Suppressive effect of the anesthetic propofol on the T cell function and T cell-dependent immune responses","volume":"14","author":"Yamamoto","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102913_bib0059","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2413719","article-title":"Benzodiazepines compromise the outcome of cancer immunotherapy","volume":"13","author":"Mont\u00e9gut","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2026.102913_bib0060","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002287","article-title":"Concomitant exposure to benzodiazepines during pembrolizumab-based therapy for advanced non-small-cell lung cancer: a propensity-score matched analysis of monitoring agency data","volume":"6","author":"Nelli","year":"2025","journal-title":"Explorat Target Anti-Tumor Ther"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102913_bib0061","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70081","article-title":"Impact of exposure to benzodiazepines on adverse effects and efficacy of PD-1\/PD-L1 blockade in patients with non-small cell lung cancer","volume":"16","author":"Takagaki","year":"2025","journal-title":"Thorac Cancer"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102913_bib0062","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.52.3.473","article-title":"Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy","volume":"52","author":"Petroff","year":"1999","journal-title":"Neurology"},{"issue":"Supplement_1","key":"10.1016\/j.jcyt.2026.102913_bib0063","article-title":"GABA exerts anti-inflammatory and immunosuppressive effects (P5175)","volume":"190","author":"Prud\u2019homme","year":"2013","journal-title":"J Immunol"},{"issue":"4\u20136","key":"10.1016\/j.jcyt.2026.102913_bib0064","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/ars.2021.0243","article-title":"Novel anticancer strategy by targeting the gut microbial neurotransmitter signaling to overcome immunotherapy resistance","volume":"38","author":"Leung","year":"2023","journal-title":"Antioxidant Redox Signal"},{"key":"10.1016\/j.jcyt.2026.102913_bib0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12943-025-02413-8","article-title":"Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors","volume":"24","author":"Yang","year":"2025","journal-title":"Molecul Cancer"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:27:35Z","timestamp":1783337255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1465324926008741"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102913","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102913"}}